[The Bell] Synthesis Biotech prepares management innovation committee, 'strengthening internal controls'
Predicted impact: Low
Management innovation committee plan already reported recently; internal governance step
Synteka Bio신테카바이오
226330 · KOSDAQ · ₩226330 · 신테카바이오
₩1,034▼ ₩25 (2.36%)End-of-day · Oct 30, 2026 · End-of-day prices.
Shinteka Biotech moves to set up management innovation committee, tightening fund controls and restructuring
Predicted impact: Medium
Management restructuring and fund controls at a small company after governance concerns.
[The Bell] Shintec Bio: "Improved new drugs and cancer vaccine candidates supplied directly to pharma companies"
Predicted impact: Low· Actual: −4.7% vs sector, volume 0.5× normal (5 trading days)
Shareholder meeting and holding report; routine governance notices for a small company.
Also known as: Synteka Bio / 신테카바이오 / 226330 / KRX:226330
Source: KRX statistical information